KUBTEC announced the launch of a new innovation in the treatment of breast cancer. The Mozart Supra Specimen Tomosynthesis System will be on display at the Radiological Society of North America (RSNA) in Chicago, IL, Nov. 25-29, 2018.
Built on KUBTECs proprietary specimen tomosynthesis technology, The MOZART Supra Specimen Tomosynthesis System is the latest generation of 3-D imaging for breast cancer surgery. The Mozart Supra System provides surgeons, radiologists and pathologists with the most advanced tools to provide the best quality of care for breast cancer patients.
Tomosynthesis has proven to be more effective than traditional 2-Dimensional imaging at identifying cancer in mammography and is now available for specimen imaging in the operating room and pathology lab. This 3-D imaging technology enables surgeons to reduce the need for repeat surgeries and assists them in achieving more pleasing cosmetic outcomes for their patients.
John Leach, vice president of marketing at KUBTEC, said, “With the introduction of the Mozart Supra System, breast surgeons and pathologists can now view 3-Dimensional images of specimens of all sizes, from lymph nodes to mastectomies, solid organs and bone. What’s more, the system uses an advanced Augmented Intelligence to aid the physician with image interpretation and includes voice activation for hands free usage in the OR.”
The MOZART Supra and MOZART Systems from KUBTEC are the onlyintraoperative breast specimen imaging systems to use tomosynthesis. Other features of the MOZART Supra include: auto-magnification, KUBTEC’s patented Image Blender and a high definition optical camera.
More details on the KUBTEC Mozart Supra Specimen Tomosynthesis System can be found at: www.kubtec.com/supra
August 14, 2026 
